{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:16Z","timestamp":1792643896645,"version":"4.5.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Classification of primary cutaneous lymphomas (PCLs) is the subject of ongoing controversy. Based on a series of 556 patients, the applicability of the European Organization for Research and Treatment of Cancer (EORTC) classification for PCLs was assessed and compared to the proposed World Health Organization (WHO) classification of hematologic malignancies. The large majority of patients could be properly classified according to the scheme proposed by the EORTC. Comparison of estimated 5-year survival for specific diagnostic categories of PCLs demonstrated nearly complete concordance of the present results with those of the EORTC study for most of the indolent cutaneous T-cell lymphomas and cutaneous B-cell lymphomas, whereas differences were found for mycosis fungoides-associated follicular mucinosis and Sezary syndrome. A few patients with newly described entities (CD8+ epidermotropic cytotoxic T-cell lymphoma, primary cutaneous natural killer\/T-cell lymphoma) could not be classified according to the EORTC scheme. Comparison of the EORTC with the WHO classification showed that the EORTC scheme allows a more precise categorization of the patients, especially for cutaneous B-cell lymphoma. In conclusion, the study confirmed that the EORTC classification allows a better management of patients with PCL. Small amendments to that classification should be carried out to account for recently described entities and to unify some of the diagnostic categories.<\/jats:p>","DOI":"10.1182\/blood.v99.3.800","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:40Z","timestamp":1027759600000},"page":"800-805","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":225,"title":["Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients"],"prefix":"10.1182","volume":"99","author":[{"given":"Regina","family":"Fink-Puches","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Zenahlik","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ba\u0308ck","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Smolle","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Kerl","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021216354333500_B1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas.","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet."},{"key":"2020021216354333500_B2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood."},{"key":"2020021216354333500_B3","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer.","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood."},{"key":"2020021216354333500_B4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.1997.tb00801.x","article-title":"The revised European-American classification of lymphoid neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas.","volume":"24","author":"Sander","year":"1997","journal-title":"J Cutan Pathol."},{"key":"2020021216354333500_B5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00000372-199906000-00012","article-title":"The revised European-American Classification of Lymphoid Neoplasm (REAL): a preferred approach for the classification of cutaneous lymphomas.","volume":"21","author":"Sander","year":"1999","journal-title":"Am J Dermatopathol."},{"key":"2020021216354333500_B6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"Conference report. The World Health Organization classification of neoplastic disease of the haematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee, Airlie House, Virginia, November 1997.","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology."},{"key":"2020021216354333500_B7","first-page":"3637","article-title":"Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary syndrome.","volume":"93","author":"Grange","year":"1999","journal-title":"Blood."},{"key":"2020021216354333500_B8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0190-9622(87)70068-1","article-title":"Primary cutaneous large cell lymphomas of follicular center cell origin. A clinical follow-up study of nineteen patients.","volume":"16","author":"Willemze","year":"1987","journal-title":"J Am Acad Dermatol."},{"key":"2020021216354333500_B9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1711720110","article-title":"Primary cutaneous T-cell lymphoma: clinicopathological features and prognosis parameters of 35 cases other than mycosis fungoides and CD-30-positive large cell lymphoma.","volume":"172","author":"Beljaards","year":"1994","journal-title":"J Pathol."},{"key":"2020021216354333500_B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.1989.tb00875.x","article-title":"Primary cutaneous follicular centre cell-lymphoma: a lymphoproliferative disease with favourable prognosis.","volume":"14","author":"Pimpinelli","year":"1989","journal-title":"Clin Exp Dermatol."},{"key":"2020021216354333500_B11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0190-9622(90)70055-M","article-title":"Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections. A comparative study.","volume":"22","author":"Cerroni","year":"1990","journal-title":"J Am Acad Dermatol."},{"key":"2020021216354333500_B12","first-page":"173","article-title":"A simplified method of detection of clonal rearrangements of the T-cell receptor-\u03b3 chain gene.","volume":"1","author":"McCarthy","year":"1992","journal-title":"Diagn Mol Pathol."},{"key":"2020021216354333500_B13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/jcp.43.11.888","article-title":"Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction.","volume":"43","author":"Wan","year":"1990","journal-title":"J Clin Pathol."},{"key":"2020021216354333500_B14","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol."},{"key":"2020021216354333500_B15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-662-05748-3","volume-title":"Angewandte Statistik. Anwendung Statistischer Methoden.","author":"Sachs","year":"1984"},{"key":"2020021216354333500_B16"},{"key":"2020021216354333500_B17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/sder.2000.8326","article-title":"Controversies in cutaneous lymphomas.","volume":"19","author":"Kerl","year":"2000","journal-title":"Semin Cutan Med Surg."},{"key":"2020021216354333500_B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00000372-199906000-00011","article-title":"EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management.","volume":"21","author":"Willemze","year":"1999","journal-title":"Am J Dermatopathol."},{"key":"2020021216354333500_B19","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","article-title":"Cell adhesion receptors in lymphoma dissemination.","volume":"95","author":"Drillenburg","year":"2000","journal-title":"Blood."},{"key":"2020021216354333500_B20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0190-9622(94)70037-0","article-title":"Disseminated pagetoid reticulosis: need for long term follow-up.","volume":"30","author":"Yagi","year":"1994","journal-title":"J Am Acad Dermatol."},{"key":"2020021216354333500_B21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.3880088","article-title":"Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study.","volume":"13","author":"Haghighi","year":"2000","journal-title":"Mod Pathol."},{"key":"2020021216354333500_B22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008397323199","article-title":"Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features.","volume":"9","author":"Bernengo","year":"1998","journal-title":"Ann Oncol."},{"key":"2020021216354333500_B23","first-page":"494","article-title":"Sezary syndrome (SS): a descriptive study of 29 cases [abstract].","volume":"109","author":"Marti","year":"1997","journal-title":"J Invest Dermatol."},{"key":"2020021216354333500_B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.1994.tb00549.x","article-title":"Classification of primary cutaneous T-cell lymphomas.","volume":"24","author":"Willemze","year":"1994","journal-title":"Histopathology."},{"key":"2020021216354333500_B25","first-page":"100","article-title":"Sezary syndrome: diagnostic criteria and therapeutic options.","volume":"19","author":"Russel-Jones","year":"2000","journal-title":"Semin Cutan Med Surg."},{"key":"2020021216354333500_B26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archinte.1980.00330220038015","article-title":"Hemophagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis.","volume":"140","author":"Winkelmann","year":"1980","journal-title":"Arch Intern Med."},{"key":"2020021216354333500_B27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1993.01680300099016","article-title":"Subcutaneous T-cell lymphoma: report of two additional cases and further observations.","volume":"129","author":"Perniciaro","year":"1993","journal-title":"Arch Dermatol."},{"key":"2020021216354333500_B28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol."},{"key":"2020021216354333500_B29","first-page":"55","article-title":"Natural killer cell lymphoma","volume-title":"An Illustrated Guide to Skin Lymphoma. Oxford","author":"Cerroni","year":"1998"},{"key":"2020021216354333500_B30","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern.","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood."},{"key":"2020021216354333500_B31","first-page":"489","article-title":"Primary cutaneous follicular lymphoma.","volume":"137","author":"Cerroni","year":"2001","journal-title":"Arch Dermatol."},{"key":"2020021216354333500_B32","first-page":"5","article-title":"Cutaneous lymphomas","volume-title":"Extranodal Lymphomas. Edinburgh","author":"Isaacson","year":"1994"},{"key":"2020021216354333500_B33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0046-8177(88)80287-9","article-title":"Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis.","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum Pathol."},{"key":"2020021216354333500_B34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma.","volume":"24","author":"Cerroni","year":"1997","journal-title":"J Cutan Pathol."},{"key":"2020021216354333500_B35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-4362.1990.tb03469.x","article-title":"Clinicopathologic study of cutaneous plasmacytoma.","volume":"29","author":"Torne","year":"1990","journal-title":"Int J Dermatol."},{"key":"2020021216354333500_B36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0190-9622(07)80014-4","article-title":"Primary plasmacytoma of the skin.","volume":"34","author":"Tuting","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"2020021216354333500_B37","first-page":"47","article-title":"Clinical outcome of extramedullary plasmacytoma.","volume":"85","author":"Galieni","year":"2000","journal-title":"Haematologica."},{"key":"2020021216354333500_B38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2133.1998.02547.x","article-title":"Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?","volume":"139","author":"Russell-Jones","year":"1998","journal-title":"Br J Dermatol."},{"key":"2020021216354333500_B39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1365-2133.1999.02994.x","article-title":"Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer classification?","volume":"141","author":"Slater","year":"1999","journal-title":"Br J Dermatol."},{"key":"2020021216354333500_B40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2133.1999.2995a.x","article-title":"Classification of primary cutaneous B-cell lymphomas.","volume":"141","author":"Sterry","year":"1999","journal-title":"Br J Dermatol."},{"key":"2020021216354333500_B41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000372-199906000-00013","article-title":"Classification of cutaneous lymphoma. A critical appraisal of recent proposals.","volume":"21","author":"Norton","year":"1999","journal-title":"Am J Dermatopathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/3\/800\/1680075\/800.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/3\/800\/1680075\/800.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T16:35:59Z","timestamp":1581525359000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/3\/800\/53472\/Primary-cutaneous-lymphomas-applicability-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.3.800","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}